Covered recipient · General Payments record
PATRICK M PORTIZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,576.30
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $382.16 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $139.00 | 7 |
| Lilly USA, LLC | $88.59 | 3 |
| EMD Serono, Inc. | $55.58 | 2 |
| Novo Nordisk AS | $45.76 | 2 |
| Theratechnologies Inc. | $30.89 | 1 |
| PFIZER INC. | $22.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| EMD Serono, Inc. | $35.58 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120221279 | CMS |
| EMD Serono, Inc. | $20.00 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120264301 | CMS |
| Lilly USA, LLC | $30.21 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135318191 | CMS |
| Lilly USA, LLC | $29.76 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135186653 | CMS |
| Lilly USA, LLC | $28.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135186651 | CMS |
| Novo Nordisk Inc | $25.94 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096912138 | CMS |
| Novo Nordisk Inc | $19.82 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097429354 | CMS |
| PFIZER INC. | $22.34 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132027313 | CMS |
| Theratechnologies Inc. | $30.89 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092907701 | CMS |
| ViiV Healthcare Company | $30.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112704984 | CMS |
| ViiV Healthcare Company | $5.83 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112780748 | CMS |
| ViiV Healthcare Company | $27.42 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112827427 | CMS |
| ViiV Healthcare Company | $7.88 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112769718 | CMS |
| ViiV Healthcare Company | $29.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112705278 | CMS |
| ViiV Healthcare Company | $5.46 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112752906 | CMS |
| ViiV Healthcare Company | $31.98 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112700447 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.